This study evaluated depression, anxiety, and patterns of mental health care in patients with prostate cancer receiving hormonal therapy such as androgen deprivation therapy (ADT). The data showed that almost half of the patients with prostate cancer receiving ADT diagnosed with depression do not receive a documented mental health treatment.

The authors aimed to determine whether taking repeated tissue samples during active surveillance can reduce erectile functioning in prostate cancer patients. 

This study examined patterns in the use of salvage therapy when primary treatment has failed.

The study aimed to investigate the rate of response (seroconversion) to SARS-Cov-2 vaccination in patients with blood cancers. This study concluded that seroconversion rates in these patients were significantly lower than that of healthy controls.  

The study evaluated the efficacy of sustained exercise training on improving physical functioning of long-term prostate cancer survivors.

This study aimed to compare different strategies of promoting bone health. This study found that educational strategies to improve bone health care are feasible and are associated with improved bone mineral density ordering in men receiving androgen deprivation therapy.

The authors aimed to determine whether aspirin had any limiting effects on mortality in prostate cancer. 

The authors aimed to determine the effectiveness of video tools in improving patient knowledge of common prostate terminology. 

This study aimed to determine whether androgen deprivation therapy (ADT) is associated with an increased risk of depression for patients with prostate cancer. It found that there was an increased risk of depression. 

This research evaluated whether resistance to hormone therapy can be delayed by giving therapeutic injections with hormone therapy intermittently (start and stop) instead of continuously in patients with prostate cancer.